Added to YB: 2024-06-14
Pitch date: 2024-06-13
ENZ [bullish]
Enzo Biochem, Inc.
-38.22%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Company Info
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.
Market Cap
$35.7M
Pitch Price
$1.13
Price Target
N/A
Dividend
14.68%
EV/EBITDA
-0.21
P/E
-4.53
EV/Sales
0.07
Sector
Life Sciences Tools and Services
Category
value
Enzo Biochem: Evaluating Value and Growth Opportunities
ENZ: Net cash of $0.80/share + remainco worth $0.88-$1.30/share vs $1.16 price. CEO options at $2 strike & activist stakes at $2-$3 signal upside. Remainco growing: Q1 sales +14% YoY, 50% GM, profitable. But cash not returned post-sale & valuation uncertain. Covered on SSI Mar '23.
Read full article (2 min)